SAVA
Cassava Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.32
+2.33%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-122.3%
Return on equity
-76.9%
Return on assets
-128.2%
Return on invested capital
0.00x
Asset turnover
-$32.3M
Cash from operations
$1.98
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025